Compare TRNS & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRNS | THQ |
|---|---|---|
| Founded | 1964 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 807.1M | 784.0M |
| IPO Year | 1995 | N/A |
| Metric | TRNS | THQ |
|---|---|---|
| Price | $81.84 | $18.40 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $104.33 | N/A |
| AVG Volume (30 Days) | 115.3K | ★ 128.1K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $331,877,000.00 | N/A |
| Revenue This Year | $12.37 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $585.00 | ★ N/A |
| Revenue Growth | ★ 19.20 | N/A |
| 52 Week Low | $50.23 | $16.28 |
| 52 Week High | $100.00 | $20.39 |
| Indicator | TRNS | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 52.82 |
| Support Level | $79.35 | $18.40 |
| Resistance Level | $93.82 | $18.97 |
| Average True Range (ATR) | 2.84 | 0.35 |
| MACD | -0.41 | 0.15 |
| Stochastic Oscillator | 20.26 | 78.33 |
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.